PSA Doubling Time
Calculate PSA doubling time from two PSA test results to monitor prostate cancer progression. Free PSA DT calculator with trend charts, velocity, slope, and clinical interpretation.
About This Calculator
The PSA Doubling Time (PSA DT) calculator is a clinical tool for patients and healthcare providers to monitor Prostate-Specific Antigen (PSA) progression over time. It calculates how quickly your PSA level is doubling — a key metric in prostate cancer surveillance, recurrence detection, and treatment response assessment.
This calculator uses the standard formula: PSA DT = ln(2) × Δt / ln(PSA₂/PSA₁), where Δt is the time between two PSA tests in months, and PSA₁ and PSA₂ are the initial and current PSA levels in ng/mL. It also computes the PSA velocity (absolute change per year) and the logarithmic slope, providing a comprehensive picture of PSA kinetics.
A PSA doubling time greater than 6 months is generally considered a favorable prognostic indicator, suggesting slower disease progression and potentially less aggressive treatment requirements. A doubling time under 6 months warrants further investigation and may indicate more aggressive disease. After radical prostatectomy, any detectable PSA rise (above 0.2 ng/mL) with a rapid doubling time is concerning for biochemical recurrence.
PSA doubling time is most commonly used in the United States and Europe for monitoring prostate cancer patients undergoing active surveillance, after definitive therapy, or during androgen deprivation therapy. In India and the UK, it is similarly used alongside PSA density, multiparametric MRI, and biopsy findings as part of comprehensive prostate cancer management. This calculator is for educational and reference purposes only — always consult a healthcare professional for medical decisions.
Frequently Asked Questions
What is PSA doubling time?
PSA doubling time (PSA DT) is the period it takes for your Prostate-Specific Antigen level to double in concentration. It is calculated from two PSA test results taken at different times using the formula: DT = ln(2) × Δt / ln(PSA₂/PSA₁). A shorter doubling time (under 6 months) is associated with more aggressive prostate cancer and a worse prognosis.
How is PSA doubling time calculated?
PSA doubling time is calculated using the formula: DT = ln(2) × Δt / ln(PSA₂/PSA₁), where Δt is the time between tests in months, PSA₁ is the initial PSA level, and PSA₂ is the current PSA level. The calculator also computes PSA velocity (change in PSA per year) and slope (log-transformed rate of change). Only increasing PSA values produce a meaningful doubling time.
What is a normal PSA doubling time?
In prostate cancer monitoring, a PSA doubling time greater than 6 months is considered a positive predictor associated with less aggressive disease, longer survival, and potentially less intensive treatment. A doubling time under 6 months is a negative predictor that requires further investigation and may indicate a need for more aggressive treatment.
What is the difference between PSA doubling time and PSA velocity?
PSA velocity measures the absolute rate of PSA change in ng/mL per year (PSA₂ − PSA₁ / years between tests). PSA doubling time measures how long it takes for the PSA level to double, using logarithmic growth. Velocity is useful for detecting rapid absolute changes, while doubling time better characterizes exponential growth patterns typical of cancer progression.
Can PSA doubling time be used for prostate cancer screening?
PSA doubling time is not used for initial prostate cancer screening. It is primarily used to monitor disease progression after a prostate cancer diagnosis, to detect recurrence after treatment, and to assess treatment response. Initial screening typically uses single PSA levels with age-adjusted reference ranges.
What PSA level is considered normal?
A single PSA test result under 4 ng/mL is generally considered normal. Levels between 4 and 10 ng/mL are in the borderline or suspicious range requiring further evaluation. Levels over 10 ng/mL are significantly elevated and warrant immediate urological investigation. After prostatectomy, a PSA rise over 0.2 ng/mL is generally regarded as biochemical recurrence.
How reliable is PSA doubling time for prognosis?
PSA doubling time is a well-established prognostic marker in prostate cancer. A doubling time under 3 months is strongly associated with cancer-specific mortality, while doubling times over 12 months suggest indolent disease. However, PSA DT should always be interpreted alongside other clinical factors including Gleason score, TNM stage, and imaging findings.